Literature DB >> 19270655

Geron gets green light for human trial of ES cell-derived product.

Joe Alper.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19270655     DOI： 10.1038/nbt0309-213a

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  65 in total

1.  How do researchers decide early clinical trials?

Authors:  Hannah Grankvist; Jonathan Kimmelman
Journal:  Med Health Care Philos       Date:  2016-06

Review 2.  Stem cell transplantation in neurodegenerative disorders of the gastrointestinal tract: future or fiction?

Authors:  Subhash Kulkarni; Laren Becker; Pankaj Jay Pasricha
Journal:  Gut       Date:  2011-08-04       Impact factor: 23.059

3.  Preservation of stem cells.

Authors:  Jacob Hanna; Allison Hubel
Journal:  Organogenesis       Date:  2009-07       Impact factor: 2.500

4.  Comparative materials differences revealed in engineered bone as a function of cell-specific differentiation.

Authors:  Eileen Gentleman; Robin J Swain; Nicholas D Evans; Suwimon Boonrungsiman; Gavin Jell; Michael D Ball; Tamaryn A V Shean; Michelle L Oyen; Alexandra Porter; Molly M Stevens
Journal:  Nat Mater       Date:  2009-07-26       Impact factor: 43.841

Review 5.  Genetic therapy for the nervous system.

Authors:  William J Bowers; Xandra O Breakefield; Miguel Sena-Esteves
Journal:  Hum Mol Genet       Date:  2011-03-23       Impact factor: 6.150

Review 6.  Pluripotent stem cells in regenerative medicine: challenges and recent progress.

Authors:  Viviane Tabar; Lorenz Studer
Journal:  Nat Rev Genet       Date:  2014-02       Impact factor: 53.242

7.  Glial restricted precursors maintain their permissive properties after long-term expansion but not following exposure to pro-inflammatory factors.

Authors:  Kazuo Hayakawa; Christopher Haas; Ying Jin; Julien Bouyer; Takanobu Otsuka; Itzhak Fischer
Journal:  Brain Res       Date:  2015-10-21       Impact factor: 3.252

8.  Targeted Disruption of the β2-Microglobulin Gene Minimizes the Immunogenicity of Human Embryonic Stem Cells.

Authors:  Dachun Wang; Yuan Quan; Qing Yan; John E Morales; Rick A Wetsel
Journal:  Stem Cells Transl Med       Date:  2015-08-18       Impact factor: 6.940

9.  Musings on genome medicine: is there hope for ethical and safe stem cell therapeutics?

Authors:  Mahendra Rao; Maureen L Condic
Journal:  Genome Med       Date:  2009-07-14       Impact factor: 11.117

10.  Therapeutic cell engineering with surface-conjugated synthetic nanoparticles.

Authors:  Matthias T Stephan; James J Moon; Soong Ho Um; Anna Bershteyn; Darrell J Irvine
Journal:  Nat Med       Date:  2010-08-15       Impact factor: 53.440
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.